neoplasm
Showing NaN - NaN of 23
Tumor, Caregivers Trial run by the National Institutes of Health Clinical Center (CC) (Sham VR, Active VR)
Not yet recruiting
- Neoplasm
- Caregivers
- Sham VR
- Active VR
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 26, 2023
Samples From People With Unanticipated Response, Significant
Enrolling by invitation
- Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Specimen Banking for People With Tumors of Central Nervous
Recruiting
- Brain Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 7, 2022
Cancer, Tumor Metastasis, Radiation Oncology Trial run by the NCI (Radiation Therapy, ECI301)
Terminated
- Cancer
- +4 more
- Radiation Therapy
- ECI301
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 30, 2021
Linkage of Medicaid Enrollment Information to Surveillance,
Completed
- Neoplasm
- +3 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
May 20, 2020
Tumor, Lymphoma Trial run by the NCI (LMP400)
Completed
- Neoplasm
- Lymphoma
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 26, 2018
Infection, Cancer, Tumor Trial run by the CC (Cone-beam computed tomography (CT), Conventional Computed Tomography (CT))
Terminated
- Infection
- +4 more
- Cone-beam computed tomography (CT)
- Conventional Computed Tomography (CT)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 4, 2017
B Cell Lymphoma, Follicular Lymphoma, Tumor Trial run by the NCI (Id-KLH Vaccine, QS-21 (Stimulation-QS-21) Drug)
Completed
- B Cell Lymphoma
- +2 more
- Id-KLH Vaccine
- QS-21 (Stimulation-QS-21) Drug
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Carcinoma, Non-small-cell Lung, Metastases Trial in United States (ZD1839 (Gefitinib))
Completed
- Carcinoma
- +3 more
- ZD1839 (Gefitinib)
-
Alabaster, Alabama
- +626 more
Jan 3, 2013
Breast Cancer, Lymphoma, Tumor Trial run by the NCI (7-hydroxystaurosporine (UCN-01))
Completed
- Breast Cancer
- +3 more
- 7-hydroxystaurosporine (UCN-01)
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Genetic Factors and Interrelationships for Cancer Risk-Related
Completed
- Acquired Immunodeficiency Syndrome
- +4 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Alternative Medical Therapies in Adult Cancer Patients Enrolled
Completed
- Neoplasm
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Tissue Acquisition for Molecular Diagnostics
Completed
- Neoplasm
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Immunological and Stem Cell Function in Peripheral Blood
Completed
- Immunologic Deficiency Syndrome
- +3 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Tumor Trial run by the NCI (ZD1694 (TOMUDEX))
Completed
- Neoplasm
- ZD1694 (TOMUDEX)
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Suction Blisters in Urticaria, Blistering Diseases, Inflammatory
Completed
- Dermatitis
- +4 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Kidney Disease, Tumor, Tumor Metastasis Trial run by the NCI (Oxaliplatin)
Completed
- Kidney Disease
- +2 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Tumor Trial run by the NCI (Radiotherapy)
Completed
- Neoplasm
- Radiotherapy
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Tumor Trial run by the NCI (collaboration)
Completed
- Neoplasm
- collaboration
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Process and Outcomes of Pain Management
Completed
- Pain
- Neoplasm
-
Bethesda, MarylandNational Institutes of Health Clinical Center (CC)
Mar 3, 2008
Tumor Trial run by the NCI (Gamma-camera imaging, Low-risk biopsy)
Completed
- Neoplasm
- Gamma-camera imaging
- Low-risk biopsy
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Tumor Trial run by the NCI (Radiotherapy)
Completed
- Neoplasm
- Radiotherapy
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008